Download PDF
Thromb Haemost 1992; 68(05): 624
DOI: 10.1055/s-0038-1646331
Letter to the Editor
Schattauer GmbH Stuttgart

No Increase of β2-Glycoprotein I Levels in Patients with Antiphospholipid Antibodies

E De Benedetti
Haemostasis Unit, University Hospital Geneva, Switzerland
,
G Reber
Haemostasis Unit, University Hospital Geneva, Switzerland
,
P A Miescher
*   Haematology Division, University Hospital Geneva, Switzerland
,
P de Moerloose
Haemostasis Unit, University Hospital Geneva, Switzerland
› Author Affiliations
Further Information

Publication History

Received 06 May 1992

Accepted after revision 22 June 1992

Publication Date:
04 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • REFERENCES

  • 1 Galli M, Comfurius P, Maassen C, Hemker HC, de Baets MH, van Breda-Vriesman PJC, Barbui T, Zwaal RFA, Bevers EM. Anticar-diolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990; 335: 1544-1547
    CrossrefPubMedGoogle Scholar
  • 2 McNeil HP, Simpson RJ, Chesterman CN, Krilis SA. Anti-phos-pholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: β2-glycoprotein I (Apolipo-protein H). Proc Natl Acad Sci. 1990; 87: 4120-4124
    PubMedGoogle Scholar
  • 3 Bevers EM, Galli M. β2-glycoprotein I for binding of anticardiolipin antibodies to cardiolipin. Lancet. 1990; 336: 952-953
    PubMedGoogle Scholar
  • 4 Koike T, Matsuura E. What is the “true” antigen for anticardiolipin antibodies? Lancet. 1991; 337: 671-672
    PubMedGoogle Scholar
  • 5 Galli M, Cortelazzo S, Daldossi M, Barbui T. Increased levels of β2-glycoprotein I (aca-cofactor) in patients with lupus anticoagulant. Thromb Haemostas 1992; 67: 386
    PubMedGoogle Scholar
  • 6 McNeil HP, Hunt JE, Krilis SA. New aspects of anticardiolipin antibodies. Clin Exp Rheumatol 1990; 8: 525-527
    PubMedGoogle Scholar
  • 7 Reber G, Roisin J-P, Vogel J-J, Martinoli J-L, de Moerloose P. An improved platelet neutralization procedure as confirmatory test for the presence of lupus anticoagulant. Thromb Haemostas 1991; 65: 1103 (abstr)
    PubMedGoogle Scholar
  • 8 Reber G, Tremblet C, Bernard C, Mermillod B, de Moerloose P. Anticardiolipin antibodies and thrombosis: buffer's influence on the detection and quantitation of anticardiolipin antibody measured by ELISA. Thromb Res 1990; 57: 215-226
    CrossrefPubMedGoogle Scholar
  • 9 Oosting JD, Derksen RHWM, Entjes HT, Bouma BN, de Groot PG. Lupus anticoagulant activity is frequently dependent on the presence of β2-glycoprotein I. Thromb Haemostas. 1992; 67: 499-502
    PubMedGoogle Scholar